Mast cells are implicated in the innate proinflammatory immune defence against bacterial insult, but the mechanisms through which mast cells respond to bacterial encounter are poorly defined. Here, we addressed this issue and show that mast cells respond vividly to wild type Streptococcus equi by up-regulating a panel of proinflammatory genes and by secreting proinflammatory cytokines. However, this response was completely abrogated when the bacteria lacked expression of sagA, whereas the lack of a range of other potential virulence genes (seeH, seeI, seeL, seeM, hasA, seM, aroB, pyrC, and recA) had no effect on the amplitude of the mast cell responses.
| INTRODUCTION
When pathogens encounter the host, they face physical barriers of the innate immune system, for example, skin or mucosae, which also contain a large array of cell types that sense and react to the foreign invader (Yatim & Lakkis, 2015) . Mast cells, derived from the haematopoietic lineage, are strategically localised at sites close to the exterior and have therefore been strongly implicated in the first line host defence against infection by bacterial and other pathogens (Dawicki & Marshall, 2007; Marshall, 2004) . A main characteristic of mast cells is their high content of secretory granules, filled with a plethora of preformed inflammatory mediators, including proteases, chemokines, cytokines, proteoglycans, and histamine (Wernersson & Pejler, 2014) . In addition to these stored components, which can be released into the environment in minutes, mast cells can de novo synthesise inter alia cytokines, prostaglandins, and growth factors to communicate and interact with their environment and other immune cells (Wernersson & Pejler, 2014) . has also been demonstrated that mast cells express a panel of pattern recognition receptors such as toll-like receptors (TLRs), which has led to the notion that mast cells could also directly respond bacterial infection (reviewed in Abraham & St John, 2010; Johnzon, Rönnberg, & Pejler, 2016; Marshall, 2004) . Indeed, animals lacking mast cells or individual mast cell components have been shown to respond differentially to bacterial infection in comparison with wild type (WT) controls (Chan, St John, & Abraham, 2013; Dahdah et al., 2014; Di Nardo, Yamasaki, Dorschner, Lai, & Gallo, 2008; Echtenacher, Mannel, & Hultner, 1996; Malaviya, Ikeda, Ross, & Abraham, 1996; Piliponsky et al., 2010; Piliponsky et al., 2012; Thakurdas et al., 2007; van den Boogaard et al., 2014) . A role for mast cells in regulating the host defence against bacterial infection has therefore emerged (Abraham & St John, 2010; Johnzon, Rönnberg, & Pejler, 2016; Marshall, 2004) .
Intriguingly, previous studies have revealed that mast cells can respond in fundamentally different ways to bacterial challenge, depending on the particular bacterial species and even strains thereof (Johnzon, Rönnberg, & Pejler, 2016) . In fact, whereas most studies suggest a beneficial role of mast cells, there are other studies pointing to a detrimental (or even dispensable) role of mast cells under different settings of bacterial challenge (reviewed in Johnzon, Rönnberg, & Pejler, 2016) . In line with this notion, the direct response of mast cells varies substantially depending on the nature of the bacterium. For example, mast cells degranulate when they encounter Escherichia coli (E. coli) (Malaviya, Ross, Jakschik, & Abraham, 1994) or Staphylococcus aureus (Abel et al., 2011) but not in response to Mycobacterium tuberculosis (Garcia-Rodriguez, Goenka, Alonso-Rasgado, HernandezPando, & Bulfone-Paus, 2017) or Streptococcus equi (Rönnberg, Guss, & Pejler, 2010) . It has also been demonstrated that, whereas Streptococcus faecium and E. coli are phagocytosed by mast cells (Arock et al., 1998 ), Listeria monocytogenes is not (Dietrich et al., 2010) . Further, Sutherland et al. demonstrated that mast cells induce killing of intracellular Klebsiella pneumoniae (Sutherland, Olsen, McKinstry, Villalta, & Wolters, 2008) . Finally, there are indications that mast cells can produce extracellular traps as a means of combating inter alia bacterial pathogens such as Streptococcus pyogenes (von Kockritz-Blickwede et al., 2008) or L. monocytogenes (CampilloNavarro et al., 2017) .
Altogether, from previous research efforts, a complex picture emerges in which mast cells can respond in multiple ways to bacterial infection and differentially impact on the host responses depending on the nature of the bacterial insult and the particular setting. However, several central issues remain to be fully addressed. One important, and partly unanswered, question regards the mechanism through which mast cells are activated by bacterial encounter. Considering that mast cells express various pattern recognition receptors, a likely scenario would be that engagement of these by classical cell wall-derived pathogen-associated molecular patterns (PAMPs) trigger proinflammatory signalling. Indeed, several studies have indicated that mast cells can be activated through such mechanisms (Marshall, 2004) . However, we showed previously that, whereas primary mast cells respond vividly to live group C streptococci, they were completely refractory to heat-inactivated bacteria in which cell wall-associated PAMPs are intact (Rönnberg et al., 2010) . Moreover, whereas mast cells responded to live S. aureus by robust vascular endothelial growth factor release, they were unresponsive to stimulation by peptidoglycan, lipopolysaccharide, Pam3CSK4, and lipoteichoic acid (Johnzon, Ronnberg, Guss, & Pejler, 2016) . It has also been demonstrated that the activation of human mast cells by E. coli is independent of TLR2 and TLR4 (Kramer et al., 2008) . A generic mechanism for bacterial activation of proinflammatory responses in mast cells has therefore remained elusive. Here, we addressed this issue with the specific aim of identifying the bacterial component(s) of group C streptococci that activate proinflammatory responses in mast cells. To this end, we challenged primary mast cells with live Streptococcus equi subspecies equi (S. equi) or with S. equi mutants lacking a panel of potential virulence genes, followed by an evaluation of downstream proinflammatory responses. Our findings reveal that sagA (encoding streptolysin S [SLS])-mediated perturbation of mast cell membranes represents the major mechanism of mast cell activation in response to the bacterial challenge. Strikingly, mast cells responded with equal amplitude to low concentrations of pore-forming detergents or pneumolysin, thus demonstrating that sublytic membrane perturbation per se is a generic trigger of proinflammatory signalling in mast cells.
| RESULTS

| Mast cell activation in response to S. equi mutants lacking multiple virulence genes
To search for potential virulence factors involved in mast cell activation in response to group C streptococci, we developed mouse bone marrow-derived mast cells (BMMCs) and cocultured these with live S. equi. In the absence of bacteria, no detectable release of proinflammatory interleukin 6 (IL-6), tumour necrosis factor (TNF), or monocyte chemoattractant protein 1 (MCP-1) from mast cells was detected.
However, upon challenge with live WT S. equi, a robust release of all of these cytokines/chemokines was observed , this being in concordance with our previous observations (Rönnberg et al., 2010) . In further agreement, challenge with live bacteria also induced expression of the genes coding for IL-6, TNF, and Nr4a3 (Figure 1d-f) , the latter representing a nuclear receptor that was previously shown to be strongly induced by various mast cell activators (Lundequist, Calounova, Wensman, Ronnberg, & Pejler, 2011; Rönnberg et al., 2010) . To start identifying the bacterial factor(s) responsible for the strong mast cell response, we cocultured the BMMCs with two S. equi mutant strains, each lacking a panel of potential virulence factors (Table 1 ). In the HILM strain, genes encoding four bacterial superantigens (seeH, seeI, seeL, and seeM) are lacking, whereas the strain denoted Multi lacks hasA, seM, pyrC, sagA, and aroB. After incubation of the BMMCs with the HILM strain, mast cell responses were indistinguishable from those seen after incubation with WT bacteria (Figure 1a-f) , thus demonstrating that mast cell activation was independent of the bacterial superantigens. In contrast, the mast cell responses were completely abolished when BMMCs were challenged with the Multi strain, indicating that mast cell activation was due to the effects of either (or a combination) of the genes lacking in this strain (Figure 1a-f) . Figure 2a -f, the strains lacking seM, recA, pyrC, and aroB were all capable of inducing a robust cytokine response and triggering of inflammatory gene expression in mast cells, although the amplitude of activation showed some variability between the knockout strains.
By contrast, the mutant strain lacking sagA (Molloy, Cotter, Hill, Mitchell, & Ross, 2011) was completely unable to induce any detectable response in mast cells (Figure 2a-f) , suggesting that the effects of sagA alone are responsible for the strong proinflammatory response of mast cells challenged with the live bacteria. To assess whether the blunted response to sagA-deficient bacteria was related to differential bacterial growth rate, we followed the growth rate of WT versus
ΔsagA mutant S. equi. However, the growth characteristics of these strains were similar in the medium used for the bacteria : mast cell cocultures, arguing against such a scenario ( Figure S1A ). Further, both strains showed equal growth and morphology in the presence of mast cells ( Figure S1B,C) . A time course experiment showed that the release of IL-6, TNF, and MCP-1 was first detected 4 hr after initiation of the FIGURE 2 Streptococcus equi mutants lacking sagA fail to elicit a mast cell response.
(a-c) 1 × 10 6 BMMCs/ml were cultured either alone (Untr.) or in the presence of WT S. equi (4047; WT) or knockout strains lacking seM, recA, pyrC, aroB, or sagA as indicated (multiplicity of infection = 10). After 4 hr, conditioned media were harvested and analysed for IL-6, TNF, and MCP-1 by ELISA. Together, these findings demonstrate that sagA is the main bacterial virulence gene capable of activating mast cells.
The sagA (streptolysin associated gene cluster A) gene encodes SLS, a lytic toxin. To confirm that WT S. equi has lytic capacity and that this is absent in the sagA mutants, we performed experiments with blood agar. As seen in Figure S2 , WT S. equi indeed displayed strong haemolytic activity, which was completely abrogated by the sagA mutation. Further, all other mutants tested, that is, those except the sagA and Multi mutants, displayed lytic activity that was indistinguishable from that of WT bacteria. Hence, the haemolytic capacity of S. equi is dependent on sagA.
2.3 | sagA is the main factor causing activation of peritoneal cell-derived mast cells Malbec et al., 2007) . To study if the mast cell-activating mechanism(s) seen in BMMCs is also operative in PCMCs, we cocultured PCMCs with either WT or ΔsagA mutant bacteria, followed by the assessment of mast cell responses.
As seen in Figure 3c -e, PCMCs, similar to BMMCs, responded to (Figure 3g ). Possibly, this finding could reflect that the encounter of PCMCs with bacteria causes release of TNF from preformed stores within the mast cell granules (Gordon & Galli, 1990) , without triggering TNF gene expression.
2.4 | sagA accounts for mast cell lysis but not degranulation, and mast cell activation is not triggered by components released during mast cell lysis Figure S3A ,B). We also assessed supernatants from activated mast cells for IL-1β but did not see elevated release of this cytokine in response to live bacteria ( Figure S3C ). Hence, mast cell activation by live S. equi does not cause profound inflammasome activation. To further address whether mast cell activation is triggered by components released from lysed mast cells, we lysed mast cells by repeated freeze-thaw cycles, incubated the lysates together with viable mast cells, and then measured IL-6 release. However, we were not able to detect IL-6 release from intact mast cells in response to the mast cell lysates, arguing against also this scenario ( Figure S3D ).
To ask whether mast cell-activating components are released during the bacteria : mast cell coculture conditions, we incubated bacteria together with mast cells for 4 and 24 hr, sterile filtered the supernatants, and incubated mast cells for 24 hr with these. However, no additional IL-6 besides that present at baseline in the conditioned supernatants could be detected after the incubation ( Figure S3E ).
We also incubated mast cells with supernatants from the bacterial cultures. As seen in Figure 4b , bacterial supernatants were not able to trigger any detectable IL-6 release from the mast cells. This suggests that cell-cell contact is needed for mast cell activation mediated by bacteria-derived SLS.
To address whether encounter of mast cells with the live bacteria causes mast cell degranulation, we measured the levels of histamine in the culture supernatants taken after incubation of mast cells with BMMCs/ml) were cultured either alone (untreated), treated with 1-μM calcium ionophore A23187, or in the presence of WT (4047) or ΔsagA mutant S. equi (multiplicity of infection = 10). At the time points indicated, conditioned media were harvested and analysed for histamine by ELISA. Data are given as mean values ± standard error of the mean, pooled from at least three biological replicates. Twofactor analysis of variance was performed with Tukey's post hoc test.
*** p ≤ .001; n.s., not significant S. equi. As a positive control, we used the calcium ionophore A23187.
As shown in Figure 4c , only slow release of histamine was seen in response to live bacteria, and the total amount of histamine release was relatively low. In contrast, calcium ionophore, as expected, triggered a rapid and more profound histamine release. This indicates that the live bacteria do not induce substantial mast cell degranulation.
Altogether, our findings indicate that mast cell activation co-occurs with cellular lysis but is not triggered by mast cell products released during lysis or degranulation.
| Mast cell activation precedes cellular lysis
To achieve a more precise view of the interaction between mast cells and streptococci, we utilised live microscopy using propidium iodide (PI) to stain lysed mast cells. As seen in Figure 5a and Videos S1 and By using the live imaging approach, we were also able to quantify the extent of PI positivity over time, thus enabling a kinetic assessment of mast cell lysis. As seen in Figure 5b and Videos S2 and S3, no detectable mast cell lysis was seen up to 4 hr of coculture of mast cells with WT S. equi, and only limited cell lysis was seen at 6-hr incubation. Thereafter, rapid cell lysis occurred with complete cell lysis noted at 8 hr of incubation (saponin was used as positive control for complete lysis). Again, no lysis was seen after coculture of mast cells with ΔsagA mutant bacteria. Importantly, these findings show that the onset of mast cell lysis (8 hr and onwards) occurs substantially later than the onset of proinflammatory events, as detected by cytokine release (see Figure 2g-i) . Hence, mast cell activation is an event that precedes mast cell lysis.
| Sublytic membrane perturbation mimics the effect of sagA
The results above indicate that bacterial sagA causes lytic cell death in mast cells and that the effects of sagA are sufficient to trigger full mast cell activation in terms of inflammatory gene expression. We next asked whether the membrane perturbation in itself could constitute a trigger for mast cell activation. To address this possibility, we first incubated mast cells with increasing concentrations of saponin, followed by measurement of cell lysis and release of IL-6.
Saponin is a gentle detergent that, similar to SLS, is known to introduce small pores in a target membrane (Seeman, 1967) . As depicted in Figure 6a , saponin concentrations up to 0.015% did not cause any detectable cell lysis, whereas 0.018-0.025% saponin resulted in partial lysis. Saponin concentrations of 0.03% and above caused complete mast cell lysis. Intriguingly, incubation of BMMCs with low concentrations of saponin induced expression of IL-6, at levels similar to those seen after incubation of mast cells with live WT S. equi (see Figure 1) . It is also notable that IL-6 release was seen at saponin concentrations starting at 0.012-0.015%, that is, at clearly sublytic concentrations, whereas the cytokine response was abrogated at higher (lytic) concentrations of saponin. Low concentrations of saponin also triggered proinflammatory gene expression in mast cells (Figure 6b-d) . These findings suggest that mast cell activation by S. equi SLS can be fully phenocopied by low concentrations of the membrane-integrating detergent saponin. This reveals a general mechanism of mast cell activation through subtle perturbation of the plasma membrane. To ask whether lytic mechanisms beyond those represented by sagA and saponin cause similar mast cell activation responses, we also evaluated the detergent digitonin and pneumolysin, the latter a lytic toxin expressed by Streptococcus pneumoniae. As shown in Figure   S4A ,B, digitonin caused a profound activation of mast cells in terms of IL-6 secretion. Similar to saponin and sagA, mast cell activation was seen at digitonin concentrations below those causing overt mast cell lysis. Pneumolysin also caused profound mast cell activation, as measured by IL-6 secretion. Similar to digitonin, saponin, and sagA, effects on IL-6 secretion were seen at pneumolysin concentrations below those causing substantial mast cell lysis ( Figure S4C,D) . Altogether, these findings suggest that multiple lytic agents/mechanisms have strong activating effects on mast cells. Further, our data indicate that maximal mast cell activation in response to all of these agents/mechanisms is seen at sublytic stages.
2.7 | Mast cell activation by sagA and saponin is dependent on the MAP kinases p38 and Erk1/2 but not on JNK However, the bacterial virulence factor(s) responsible for mast cell activation in this setting has not been identified prior to this investiga- were completely refractory to stimulation by heat-inactivated S. equi (Rönnberg et al., 2010) . In combination with the present data, this suggests that classical cell wall-associated PAMPs have minimal roles in activating mast cells in response to this group of bacteria.
The sagA gene codes for the precursor of the cytolytic toxin SLS and our data thus suggest that mast cell lysis is triggered by sagAencoded SLS. The mechanism by which sagA causes mast cell activation is however intriguing. Initially, we hypothesised that lysis of mast cells could result in the release of alarmins such as IL-33 and HMGB1
that are capable of activating surrounding viable mast cells (Tung, Plunkett, Huang, & Zhou, 2014) . However, we were not able to detect the release of alarmins after coculture of mast cells with WT S. equi.
Moreover, we did not see any mast cell-activating effect of lysed mast cells (containing a large spectrum of compounds with potential alarmin activities). We therefore regard this possibility as unlikely. Another possibility would be that sagA-dependent cell membrane perturbation per se has proinflammatory effects on mast cells. Indeed, we showed that exposure of mast cells to lytic detergents (i.e., saponin or digitonin) mirrors the effects of WT S. equi exposure. This suggests that interference with the mast cell membrane itself results in mast cell
activation.
An intriguing finding was that mast cell activation by S. equi, as assessed by induced expression of proinflammatory genes and secretion of proinflammatory cytokines, occurred several hours before the time point when cell lysis was first detected. Furthermore, we noted that the activation of mast cells by saponin or digitonin occurred at concentrations that were clearly below those required to cause overt mast cell lysis, that is, sublytic concentrations. These findings indicate that mast cell activation is triggered at the stage before actual lysis occurs, that is, at a sublytic stage. At present, we cannot with certainty explain how this response is initiated. However, it has been hypothesised that bacterial lysins from sources other than S. equi could potentially trigger cellular responses by causing osmotic stress (Carr, Sledjeski, Podbielski, Boyle, & Kreikemeyer, 2001; Flaherty, Puricelli, Higashi, Park, & Lee, 2015) . The proinflammatory effects of sagA-encoded SLS on mast cells could thus potentially be explained by such a scenario (Figure 8 ). It is also notable that mast cell activation occurred without profound degranulation, as indicated by only limited histamine release. Hence, the signalling mechanisms triggered by membrane perturbation do not appear to crosstalk with pathways leading to mast degranulation. Intriguingly, it has been shown that, in contrast to SLS, the cholesterol-dependent cytolysins streptolysin O from S. pyogenes and pneumolysin can cause mast cell degranulation (Fritscher et al., 2018; Stassen et al., 2003) , hence suggesting that the lytic toxins expressed by these three streptococcal species have differential activating impact on mast cells depending on the class of toxin. This is further supported by the observation of mast cell activation by another cholesterol-dependent cytolysin, listeriolysin O from L. monocytogenes (Gekara et al., 2007) .
In a previous study, we showed that the responses of mast cells to live S. equi required cell-cell contact, as judged by transwell experiments (Rönnberg et al., 2010) . In line with this, we show here that neither conditioned medium from S. equi cultures nor conditioned media from mast cell: S. equi cocultures had the ability to cause mast cell activation. This reinforces that mast cells need to be in physical contact with S. equi to mount a proinflammatory response, which is consistent with previous studies revealing that SLS-like toxins are only active in the context of presentation on the bacterial surface or on carrier structures (Molloy et al., 2011) . In further support, we showed by live imaging that mast cells aggregate when cocultured with S. equi.
Most likely, the mechanism of mast cell activation thus involves a first aggregation step, followed by lysis caused by SLS. It was also notable that the aggregation was more pronounced when mast cells were cocultured with ΔsagA mutant versus WT bacteria. A plausible explanation for these findings could be that the aggregation is resolved after SLS-dependent mast cell lysis and thus that the aggregation of mast cells will persist if sagA is absent. Further, this scenario implies that sagA-encoded SLS is anchored to the cell wall or, alternatively, that SLS released by S. equi is an effective lysin for mast cells only if released in proximity to the target cell (Figure 8 ). In contrast to this observation, Flaherty et al. showed that SLS expressed by (4047) or ΔsagA mutant bacteria (multiplicity of infection = 10); or WT bacteria ± MAP kinase inhibitors as in (a). Cell pellets were recovered and evaluated by western blot analysis for phosphorylation of p38 (P-p38) and Erk1/2 (P-Erk-1/2), with nonphosphorylated proteins as controls. Quantification of the western blot data is shown to the right, based on three to five independent experiments. * p ≤ .05, ** p ≤ .01, *** p ≤ .001; n.s., not significant
Streptococcus pyogenes (Molloy et al., 2011) was released into the medium and that SLS-dependent effects on keratinocytes did not require cell-cell contact (Flaherty et al., 2015) .
Mast cells have been known for decades to interact and/or become activated by bacteria and other pathogens (Johnzon, Rönnberg, & Pejler, 2016) . Although many bacteria are believed to activate mast cells via TLR signalling (Sandig & Bulfone-Paus, 2012) , this study together with a limited number of previous studies indicate that mast cell activation can be caused by cell membrane-altering cytolytic toxins (Fritscher et al., 2018; Kramer et al., 2008; Stassen et al., 2003) . As judged by the complete abrogation of mast cell responses in the absence of sagA, we propose that membraneperturbing toxins, rather than classical PAMPs, represent the dominating bacterial factors driving mast cell activation. On a more general level, bacterial lysins have been shown to activate a range of other cell types, such as keratinocytes (Flaherty et al., 2015) , neutrophils (Ma, Chang, Zhang, Zhou, & Yu, 2012) , epithelial cells (Ratner et al., 2006) , and myoblasts (Kennedy, Smith, Lyras, Chakravorty, & Rood, 2009) . Importantly, the exact mechanism for how these toxins activate immune (and other) cells remains poorly understood. In several studies, it has been shown that lysin-dependent effects on target cells cause an up-regulation of specific signalling pathways including p38 MAP kinase, Akt, and NF-κB and that the effect of bacterial lysis ultimately results in cell death (Autheman et al., 2013; Flaherty et al., 2015; Kao et al., 2011; Kennedy et al., 2009; Ma et al., 2012; Ratner et al., 2006; Wiles, Dhakal, Eto, & Mulvey, 2008) . In line with such findings, we found that mast cell activation in response to sagA was strongly dependent on MAP kinase signalling through the p38 and Erk1/2 pathways and also that the bacteria eventually caused lytic cell death of the mast cells. However, the exact mechanism linking the sublytic effects of bacterial lysins to p38/Erk1/ 2-activation and the downstream initiation of proinflammatory signalling events in mast cells remains to be fully elucidated.
Altogether, the present study identifies bacteria-derived sagA as a major stimulus for mast cell activation and reveals that sagA and low levels of detergents and pneumolysin activate mast cells by a sublytic mechanism, leading to proinflammatory gene expression and cytokine release ( Figure 8 ).
| EXPERIMENTAL PROCEDURES
| Cultured primary mast cells
BMMCs were derived from C57BL/6J mice and were cultured as described (Rönnberg & Pejler, 2012) . PCMCs were generated and cultured as described (Malbec et al., 2007; Waern et al., 2012) . 
| Bacteria
WT Streptococcus equi subsp. equi (strain 4047) and mutant strains were as described (Paillot et al., 2010; Robinson et al., 2015;  
| Quantitative real time RT-PCR (qPCR)
Total RNA from cell pellets was extracted following the manufacturer's protocol (NucleoSpin ® RNA, Machery-Nagel, Germany) but excluding the viscosity filtering step (6.1 step 3 described in the manual). Equal concentrations of RNA (NanoDrop) were converted to cDNA (iScript ™ cDNA Synthesis Kit, Bio-Rad) and stored at −20°C; 1 μl of each cDNA was added to 9 μl of master mix: 5-μl iTaq Table S1 ). Samples were analysed in duplicates on 384-well microtiter plates (Sarstedt, Nümbrecht, Germany) with centrifugation 5 min 
| Western blot
Pellets from 1 × 10 6 BMMCs were lysed in SDS-PAGE sample buffer (2.5% 2-mercaptoethanol [Sigma], 2% SDS, 10% glycerol, and 0.002% μl bromphenol blue), boiled for 5 min at 99°C in a heating block and applied to gels (4-20%); 5-μl ladder was added and SDS-PAGE was run at 100 V. We used GLASS gels (WSHT, Shanghai, China), 
| LDH assay
LDH release was measured by the Pierce ™ LDH Cytotoxicity Assay Kit (ThermoFisher Scientific), following the manufacturer's instructions.
Lysed BMMCs (using supplied lysis buffer) were used as positive control for total LDH content. For these assays, mast cell : bacterial cocultures were performed in phenol red-free DMEM (ThermoFisher Scientific).
| Flow cytometry
Cell lysis was determined by flow cytometry using DRAQ7 staining (Biostatus, Shepshed, UK), utilising a BD Accuri ™ C6 Plus instrument (BD Biosciences, San Jose, CA). Digitonin was purchased from Sigma-Aldrich (Steinheim, Germany), and pneumolysin was provided by MyBioSource (MBS1141054, expressed in E. coli, LPS free;
San Diego, CA).
| Haemolysis
Haemolytic activity was determined by identifying a zone of β haemolysis surrounding colonies of the mutant strains of S. equi following overnight growth on COBA streptococcal selective agar at 37°C in a humidified atmosphere containing 5% CO 2 .
| Statistical analysis
Data are presented generally as mean ± standard error of the mean. 
